{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:21:39Z","timestamp":1788268899938,"version":"build-2803163510"},"reference-count":43,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2071528","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T07:17:52Z","timestamp":1651735072000},"page":"630-639","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Annual indirect cost savings in patients with episodic or chronic migraine: post-hoc analyses from multiple galcanezumab clinical trials"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0564-859X","authenticated-orcid":false,"given":"Joshua","family":"Tobin","sequence":"first","affiliation":[{"name":"Neurosciences Clinic, Banner University Medical Center, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet H.","family":"Ford","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Tockhorn-Heidenreich","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Bracknell, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell M.","family":"Nichols","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Ye","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Mi","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA"},{"name":"TechData Service Company, King of Prussia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Sharma","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, Bronx, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-020-00221-w"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-018-0113-0"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2020.88547"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13301"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01243-5"},{"key":"e_1_3_5_7_1","unstructured":"Bonafede M Sapra S Shah N et\u00a0al. Direct indirect healthcare resource utilization and costs among migraine patients in the United States. Headache. Avaibale on https:\/\/www.ajmc.com\/view\/study-summary-costs-associated-with-migraine-in-the-united-states."},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03612.x"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-020-01191-6"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1068-y"},{"key":"e_1_3_5_11_1","unstructured":"Polson M Williams TD Speicher LC et\u00a0al. [cited 2021 October 4]. Available from: https:\/\/www.ajmc.com\/view\/total-cost-of-care-in-patients-with-migraine-a-realworld-claims-analysis."},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.1212"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418779543"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006640"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30279-9"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-020-02623-1"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13970"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-018-0105-0"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d20"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102413485658"},{"key":"e_1_3_5_21_1","unstructured":"Gross Domestic Product (GDP) per capita international $(PPP-adjusted). [cited 2021 October 4]. Available on https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/1145."},{"key":"e_1_3_5_22_1","unstructured":"Work Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI:GH). [cited 2021 August 2]. Available on http:\/\/oml.eular.org\/sysModules\/obxOML\/docs\/id_98\/WPAI-GH_English_US_V2.pdf."},{"key":"e_1_3_5_23_1","unstructured":"The Migraine Disability Assessment Test. [cited 2021 June 15]. Available on https:\/\/headaches.org\/wp-content\/uploads\/2018\/02\/MIDAS.pdf."},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14130"},{"key":"e_1_3_5_25_1","unstructured":"World Economic Outlook Database. Gross Domestic Product Per Capita 2021. US. [cited 2021 August 2]. Available on https:\/\/www.imf.org\/en\/Publications\/WEO\/weo-database\/2021\/April\/select-country-group."},{"key":"e_1_3_5_26_1","unstructured":"Work Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI:GH). [cited 2021 October 4]. Available on https:\/\/oml.eular.org\/sysModules\/obxOML\/docs\/id_98\/WPAI-GH_English_US_V2.pdf."},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7461-2"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2021.04.1281"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-0993-0"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2020.20100"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0000000000000781"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/11531180-000000000-00000"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01362-z"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0972753120929563"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1097\/JOM.0b013e31821488ed"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.1.22"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13657"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01310-x"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01305-8"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00305-5"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1925557"},{"issue":"1","key":"e_1_3_5_42_1","first-page":"1","article-title":"P0218. Adherence and persistence to preventive migraine treatments over 12 months follow-up for patients with migraine: calcitonin gene-related peptide monoclonal antibodies versus other preventive treatments","volume":"41","author":"Varnado O","year":"2021","unstructured":"Varnado O, Manjelievskaia J, Ford F, et\u00a0al. P0218. Adherence and persistence to preventive migraine treatments over 12 months follow-up for patients with migraine: calcitonin gene-related peptide monoclonal antibodies versus other preventive treatments. Cephalalgia. 2021;41(1S):1\u2013227.","journal-title":"Cephalalgia"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02091.x"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.suppl_1.S20"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2071528","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:17:29Z","timestamp":1729163849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2071528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2071528"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2071528","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-01-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}